You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neprilysin

Showing 1 - 25 of 134
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors

Not yet recruiting
  • Aortic Valve Stenosis
  • Angiotensin Receptor-Neprilysin Inhibitor
  • antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 4, 2023

Novel Antidiabetic Drug Combined With Angiotensin

Recruiting
  • Type 2 Diabetes
  • Antidiabetic Drugs
    • Beijing, Beijing, China
    • +1 more
    Jun 20, 2023

    Hemodialysis Trial (Sacubitril-valsartan)

    Not yet recruiting
    • Hemodialysis
    • (no location specified)
    Aug 9, 2022

    Heart Failure With Preserved Ejection Fraction Trial in Chongqing (Angiotensin Receptor-Neprilysin Inhibition, Placebo)

    Not yet recruiting
    • Heart Failure With Preserved Ejection Fraction
    • Angiotensin Receptor-Neprilysin Inhibition
    • Placebo
    • Chongqing, China
      The first affiliated Hospital of Chongqing Medical University
    Oct 21, 2021

    Myocardial Infarction, Diastolic Dysfunction Trial in Copenhagen, Odense (Valsartan+ sacubitril, Placebo Oral Tablet)

    Recruiting
    • Myocardial Infarction
    • Diastolic Dysfunction
    • Valsartan+ sacubitril
    • Placebo Oral Tablet
    • Copenhagen, Denmark
    • +1 more
    Oct 6, 2021

    Heart Failure With Reduced Ejection Fraction Trial in Porto (Sacubitril-valsartan, SGLT2 inhibitor)

    Recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Porto, Portugal
    • +3 more
    Aug 9, 2023

    Systemic Right Ventricle, Heart Failure Trial in Montreal (Sacubitril / Valsartan Oral Tablet, Placebo)

    Active, not recruiting
    • Systemic Right Ventricle
    • Heart Failure
    • Sacubitril / Valsartan Oral Tablet
    • Placebo
    • Montreal, Quebec, Canada
      Montreal Heart Institute
    Dec 21, 2022

    Pulmonary Hypertension Trial in Badalona (Sacubitril / Valsartan Oral Tablet [Entresto])

    Completed
    • Pulmonary Hypertension
    • Sacubitril / Valsartan Oral Tablet [Entresto]
    • Badalona, Barcelona, Spain
      Germans Trias i Pujol University Hospital
    Sep 23, 2021

    ARNI and ACE Inhibitor/ARB Medication in Patient With HFrEF

    Recruiting
    • Heart Failure
    • Mortality
    • Angiotensin receptor neprilysin inhibitor (ARNI)
    • Renin-Angiotensin System Inhibitor (RAS inhibitor)
    • Wonju, Gangwondo, Korea, Republic of
      Yonsei University Wonju College of Medicine
    Dec 20, 2022

    Heart Failure, Systolic Trial in Karachi (Sacubitril/valsartan)

    Completed
    • Heart Failure, Systolic
    • Karachi, Sindh, Pakistan
      National Institute of Cardiovascular Diseases
    May 20, 2022

    Heart Failure With Preserved Ejection Fraction Trial in Rochester (Entresto™ 49Mg-51 mg tablet)

    Completed
    Has Results
    • Heart Failure With Preserved Ejection Fraction
    • Entresto™ 49Mg-51 mg tablet
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 6, 2022

    Type2 Diabetes Trial in Hvidovre (Entresto, Sitagliptin, Valsartan)

    Completed
    • Type2 Diabetes
    • Hvidovre, RegionH, Denmark
      Hvidovre Hospital
    May 4, 2021

    Hypertension, Left Ventricular Hypertrophy Trial in Shanghai (sacubitril/valsartan, Amlodipine)

    Recruiting
    • Hypertension
    • Left Ventricular Hypertrophy
    • Shanghai, China
      Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Ji
    Dec 7, 2021

    Chagas Cardiomyopathy Trial in São Paulo (Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril)

    Recruiting
    • Chagas Cardiomyopathy
    • Sacubitril / Valsartan Oral Tablet [Entresto]
    • Enalapril
    • São Paulo, Brazil
      Heart Institute (Incor) University of Sao Paulo
    May 6, 2021

    Heart Failure With Reduced Ejection Fraction Trial in Leipzig, Kaiserslautern (Sacubitril-Valsartan)

    Active, not recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Leipzig, Saxony, Germany
    • +1 more
    Dec 28, 2021

    Heart Failure Trial in Saga (Sacubitril Valsartan Sodium Hydrate, Standard treatment)

    Recruiting
    • Heart Failure
    • Sacubitril Valsartan Sodium Hydrate
    • Standard treatment
    • Saga, Japan
      Saga University Hospital
    Dec 27, 2021

    Stage D Heart Failure Trial in Cleveland (Sacubitril-Valsartan, Usual care (standard-of-care) arm)

    Recruiting
    • Stage D Heart Failure
    • Cleveland, Ohio
      Cleveland Clinic
    Jun 4, 2021

    Diabetes, Type 2, Diastolic Dysfunction Trial in Rochester (LCZ 696, Placebos)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Diastolic Dysfunction
    • LCZ 696
    • Placebos
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Oct 12, 2021

    Heart Failure, Exercise Tolerance, Vasodilation Trial in São Paulo (Neprilysin, Enalapril)

    Completed
    • Heart Failure
    • +4 more
    • São Paulo, SP, Brazil
      Marcelo Rodrigues dos Santos
    Oct 21, 2020

    Immune Checkpoint Inhibitor in NSCLC Patients

    Not yet recruiting
    • Adverse Reactions
    • +3 more
    • renin-angiotensin system inhibitors or angiotensin-receptor-neprilysin inhibitor
    • (no location specified)
    Jul 15, 2020

    Hypertrophic Cardiomyopathy Trial in Worldwide (Lifestyle, Sacubitril/Valsartan)

    Completed
    • Hypertrophic Cardiomyopathy
    • Regensburg, Germany
    • +4 more
    Nov 23, 2022

    Heart Failure Trial in Worldwide (OPTIMIZER, Optimal medical therapy)

    Terminated
    • Heart Failure
    • OPTIMIZER
    • Optimal medical therapy
    • Graz, Austria
    • +7 more
    Sep 1, 2020

    Heart Failure, Systolic Trial in Hønefoss (Sacubitril / Valsartan Oral Tablet)

    Unknown status
    • Heart Failure, Systolic
    • Sacubitril / Valsartan Oral Tablet
    • Hønefoss, Buskerud, Norway
      Ringerike Hospital Vestre Viken Hospital Trust
    Aug 28, 2019

    Diabetes, Heart Failure Trial in Copenhagen (Entresto, Sitagliptin 100mg, Placebos)

    Completed
    • Diabetes
    • Heart Failure
    • Copenhagen, Denmark
      University of Copenhagen
    Jul 3, 2019

    Hypertrophic Cardiomyopathy Trial in Newcastle (Sacubitril/Valsartan, Lifestyle)

    Completed
    • Hypertrophic Cardiomyopathy
    • Newcastle, United Kingdom
      Newcastle NHS
    May 4, 2022